Vivalis — Nantes, France
SAFC® and Vivalis, a leader in embryonic stem cell technology, introduced EX-CELL® EBx® cell growth and virual production platform, designed exclusively to support the EBx duck cells used in the commercial production of prophylactic and therapeutic vaccines.
Press Release
Case Study (43 Kb PDF)
Sartorius Stedim Biotech — France
This global partnership combines Sartorius Stedim Biotech's expertise in filtration and liquid handling systems with SAFC Biosciences® proficiency in development and manufacturing of cell culture media and downstream purification products.
Press Release
Oncolytics — Calgary, Canada
SAFC Pharma® produces 40-liter batch sizes of Oncolytic's REOLYSIN®, a proprietary formulation of the human reovirus as cancer therapeutic.
Press Release
Case Study (42 Kb PDF) |
|
